We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Frontier Ip Group Plc | FIPP | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 43.50 | 07:37:29 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 43.50 | 43.50 | 43.50 | 43.50 | 43.50 |
| Industry Sector |
|---|
| NONEQUITY INVESTMENT INSTRUMENTS |
| Top Posts |
|---|
Posted at 20/3/2024 07:50 by best1467 I guess it’s the down side of investing in private companies.But you could argue they excepted Financial support from FIPP so a little more detail on the potential Financial scale of the deal without naming the company |
Posted at 18/3/2024 11:54 by rivaldo FIPP are featured on i.i.i as an AIM growth share to consider:"Frontier IP (FIPP) Price: 42p Technology investment company Frontier IP Group FIPP is different to the other companies because if it makes a profit it tends to be because of gains in its portfolio company valuations or those realised via disposals. Management’s relationships with a number of universities in the UK and Portugal provide it with opportunities. There are parts of the portfolio that are starting to mature and provide exits. The model is that Frontier IP earns stakes in technology spin-outs in return for providing advice and services and not from investing cash directly. In the six months to December 2023, the net asset value (NAV) increased from 81.8p/share to 84.2p/share thanks to higher portfolio valuations and a sale of Exscientia shares. Nasdaq listed investee company Exscientia is an example of the potential for gains, although not all early-stage portfolio investments will do well. Exscientia is a spin-out from the University of Dundee and uses artificial intelligence to help drug discovery. Frontier IP has raised £14 million from share sales, whereas the cost of the investment was less than £2,000. Another investee company Alusid, a spin-out from the University of Central Lancashire, produces sustainable tiles and could be on course for a flotation. Other investee companies are making progress with Heriot Watt University spin-out Nandi Proteins singing a commercial licence with a global food ingredients company. There was cash of £2.7 million at the end of 2023, while a further £1.7 million was subsequently raised from selling the remaining Exscientia shares. There has been a sharp recovery in the share price this year, but it is still 45% lower than at the end of 2022. The 50% discount to NAV partially reflects the fact that the portfolio is predominantly unquoted. Even so, this discount is too high and should narrow, while positive news on Alucid could provide further upside." |
Posted at 14/3/2024 07:44 by rivaldo Results are out and look highly encouraging imo.NAV has held up nicely at 84.2p given the macro environment. Cash is up to £4.4m including the final Exscientia shares sales. Above all, a number of companies look particularly exciting - namely Alusid, CamGraPhIC, Fieldwork Robotics, Nandi Proteins, Pulsiv and The Vaccine Group. A number of these are on the cusp of or are now selling product in quantity. Alusid is once again mentioned as IPO-ing soon. GraphEnergyTech and CamGraPhIC sound particularly exciting. FIPP are trading at less than 50% of NAV. Much too great a discount. |
Posted at 07/3/2024 08:00 by hastings Good catch up with the CEO yesterday and I plan to meet up with him after the Interim's in a couple of weeks time. So, I'll add my write up after that as there should be more to say then, as effectively in a closed period. For now, Nandi very much alive, but news dictated by commerciality agreements. A number of investments appear to be nearing key points, so there should be more on the news front through the year. Institutional sells down to a mix of change of fund managers and redemptions. Miton in particular has been selling a number of small cap stocks to meet redemptions, so FIPP isn't alone on that front. Happy to continue holding here as I believe the share price recent trend will reverse at some point, although I don't have my crystal ball to hand. |
Posted at 06/3/2024 09:34 by best1467 Ask Neil if he will buy some FIPP shares please |
Posted at 01/3/2024 14:35 by hastings Write up for interest https://martinflitto |
Posted at 29/2/2024 15:47 by rivaldo Glad to see that FIPP have taken advantage of the recent uptick in Exscientia's share price to offload the rest of their holding.That's another £2.54m in the bank, to recycle into the rest of the portfolio: A £14 million return for a total cost of £2,000 is pretty astonishing. Hopefully the likes of Pulsiv and others will bring in more in terms of capital return even if perhaps not quite as good in percentage terms! |
Posted at 09/2/2024 10:19 by acuere I share your frustration at the lack of news on ustake. The trouble is I’m not fully au fait with how long discussions, testing and product designs take. When we hear they are in talks with majors and then hear nothing for ages we just don’t know if talks are still ongoing or if they walked away. For now I’m happy to accept they are still on track with discussions etc.I’d also add that if I was invested in Pulsiv PLC and they were valued at say £200m then I might be more concerned. But at a value of £50m, which as Fipp share price at 40%+ discount to Nav effectively makes their value £30m I am not concerned. And remember that £50m value is from November 2022. They have made huge progress and strengthened the board since then. The other thing I’d ask is have you spoken to Pulsiv about your concerns? At least 3 posters on here have done. It might provide you with some reassurance. |
Posted at 08/2/2024 10:33 by acuere I’m still wondering what prompted Rich Ford to post this a couple of weeks ago.“ This gamechanging technology is the best thing to have happened to power supply design for decades in my opinion. Astute Electronics are moving forward with this technology and more amazing news WILL follow as Pulsiv surge forward” He has 30 years experience in the industry and is Astutes Business Development Manager. Around the same time, there was a lot of buying of Fipp shares. I feel sure he has heard something which he believes to be significant. Astute were signed up as a distributor a month before Pulsivs Osmium was launched, so they have access to info ahead of official announcements. I’m wondering if Pulsiv will announce something to coincide with APEC 2024 in California in a couple of weeks. As an interesting aside, I note that Pulsivs last accounts were quoted in dollars whereas previously they were in sterling. I read that as an indicator that as and when they do IPO it will on Nasdaq. |
Posted at 29/1/2024 10:04 by rivaldo Cheers acuere, excellent news.Here's ST's full tip for FIPP in the IC: "Back future tech winners via Frontier IP Smart technology funds are investing in tile company Alusid ahead of an IPO – and so can you through this below-the-radar investment company January 22, 2024 by Simon Thompson Portfolio attracts high-profile technology investor 50 per cent share price discount to NAV Edinburgh-based Frontier IP (FIPP:40p), a technology investment company that provides commercialisation services to university spin-outs in return for ‘free equity’ stakes, has announced a successful capital raise for portfolio company Alusid. Alusid creates premium-quality tiles and architectural surfaces by recycling industrial waste ceramics, glass and other materials, much of which would end in landfill. As part of a larger £1.13mn funding round, Octopus AIM VCT funds are investing £0.5mn in Alusid, which values the company at £9.5mn. Frontier IP holds a 35.4 per cent equity stake in Alusid worth £3.3mn. The cash proceeds will be used to support Alusid's expansion into new product ranges and territories. For instance, the company is developing hard-wearing floor tiles, which are expected to launch commercially this year, and is in discussions with potential distributors in Scandinavia and Northern Europe. It is also exploring options for an IPO later this year. There is clear momentum in Alusid’s business. In the past year, the company has launched environmentally friendly products with Topps Tiles, the UK's largest tile retailer, and is in collaboration with Imerys, a world leader in speciality minerals, to develop floor tiles. Other customers include H&M, Pret a Manger, BBC and Starbucks. Prospects for further gains on Frontier’s portfolio are being woefully undervalued. To put this into perspective, Frontier holds a liquid £2.3mn stake in Nasdaq-listed Exscientia (US: EXAI)Exscientia (US: EXAI), a clinical-stage pharmaceutical technology company, pro-forma cash of £2.5mn (after factoring in operating expenses in the past six months), a £33mn equity portfolio, £5.9mn of debt investments and £1mn of trade receivables. Ignoring the possibility of valuation uplifts in the forthcoming interim results, the £22.5mn market capitalisation company is rated on a 50 per cent discount to book value. That’s an extreme discount considering the progress being made by multiple investee companies including its largest holding, Plymouth University spin-out Pulsiv Solar, a green technology company that has developed on-chip technology to improve the energy efficiency of power supplies, battery chargers, LED lighting and photovoltaic solar cells. Frontier IP’s 18 per cent stake in Pulsiv had a read-through valuation of £9.3mn following Pulsiv's last fundraising. So, although Frontier IP’s share price is slightly shy of my last buy call (‘Bag a technology bargain buy’, 31 October 2023), there is a clear disconnect between the value embedded in an exciting investment portfolio and the price attributed to its investments by the market. Buy." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
